AstraZeneca’s COVID-19 vaccine. AFP Yonhap News
It is reported that the UK is also considering restricting the vaccination of a novel coronavirus infection (Corona 19) from a multinational pharmaceutical company AstraZeneca to young people. The vaccine was developed jointly by AstraZeneca and Oxford University in the UK, and the UK is the de facto host country. Even when European countries temporarily stopped vaccination due to side effects of blood clots (blood clotting), the UK continued to vaccination, so if this measure is implemented, the international impact is not expected to be small.
On the 5th (local time), Reuters cited the local media channel 4 news, and the UK health authorities are discussing ways to inoculate other vaccines for young people under the age of 30, considering the very rare side effects of blood clots after vaccination with AstraZeneca vaccine. Said. However, the British Medicines Regulatory Authority (MHRA) refused to say that a decision has not been made.
Earlier, when a blood clot was reported in Europe last month after receiving the AstraZeneca vaccine, and the vaccination was discontinued in more than 20 countries, MHRA expressed confidence in the safety, saying, “The benefits of vaccination are far greater than the risk of side effects.” . “There is no association between the case of a blood clot after vaccination and the vaccine,” the company also disclosed the results of its own investigation and recommended “continue vaccination”. To date, 36 million people in the UK have been vaccinated more than once.
However, it seems that the health authorities have also changed their position when the fatalities came out in the UK as well. According to a BBC broadcast on the 3rd, until recently, 7 people died of blood clots after vaccination with AstraZeneca. The BBC said, “It is not clear whether the occurrence of a blood clot is a coincidence or a side effect of the vaccine.”
Already, France, Belgium, and Canada have restricted AstraZeneca vaccination to those under the age of 55. Germany is also vaccinating only over the age of 60. Last month, the European Medicines Agency (EMA) safety committee reaffirmed the safety and efficacy of the AstraZeneca vaccine, and found that 9 cases of specific blood clot deaths are mostly women under the age of 55, and that further investigations are needed.
Kim Pyo-hyang reporter [email protected]
News directly edited by the Hankook Ilbo can also be viewed on Naver.
